The V-5 provides quick, accurate and cross-culturally valid measures of psychiatric symptoms

Sirianni, Christina D.; Abeare, Christopher A.; Ali, Sami; Razvi, Parveen; Kennedy, Arianna; Pyne, Sadie R.; Erdődi, László A.

doi:10.1016/j.psychres.2020.113651

Cited by 15 publications

(10 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As emotional wellbeing is a complex construct with often multiple determinants, partly unrelated to the disease, it can be questioned if this can be meaningfully captured by a one item VAS. Recently a 5-item VAS has been validated to screen for psychiatric symptoms, which may be a tool for further exploration in ILD [15].…”

Section: Discussionmentioning

confidence: 99%

The use of online visual analogue scales in idiopathic pulmonary fibrosis

Moor¹,

Mostard

Grutters

et al. 2021

Eur Respir J

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

The use of online visual analogue scales in idiopathic pulmonary fibrosis

Moor¹,

Mostard

Grutters

et al. 2021

Eur Respir J

View full text Add to dashboard Cite

show abstract

“…In addition to the RCFT, all patients completed a core battery of neuropsychological tests, including the Matrix Reasoning, Vocabulary, Digit Span and Coding subtests of the Wechsler Adult Intelligence Scale -Fourth Edition (WAIS-IV; Wechsler, 2008), the Trail Making Test (TMT A & B; Reitan, 1955); the Hopkins Verbal Learning Test -Revised (HVLT-R; Brandt & Benedict, 2001), letter, category and emotion word fluency (Abeare et al, 2017;Gladsjo et al, 1999), Stroop test of the Delis-Kaplan Executive Function System (D-KEFS, 2001), Grooved Pegboard Test (GPB;Lafayette Instrument, 2015), Complex Ideational Material (CIM) of the Boston Diagnostic Aphasia Battery (Goodglass et al, 2001); Conners' Continuous Performance Test -Third Edition (CPT-3;Conners, 2015), the Rey Fifteen-Item and Word Recognition Test (WRT; Rey, 1941); Boston Naming Test -Short Form , the Clock Drawing Test (CDT; Rouleau et al, 1992), the Patient Health Questionnaire (PHQ-9; Spitzer et al, 1999); the Generalized Anxiety Disorder Seven (GAD-7; Spitzer et al, 2006), the Five-Variable Psychiatric Screener (V-5; Erdodi, Jongsma, et al, 2020;Sirianni et al, 2021) and the Behavior Rating Inventory of Executive Function (BRIEF; Roth et al, 2005). Demographically adjusted Tscores for the TMT, CIM, GPB and verbal fluency were calculated using the norms by Heaton et al (2004).…”

Section: Methodsmentioning

confidence: 99%

Flipping the Script: Measuring Both Performance Validity and Cognitive Ability with the Forced Choice Recognition Trial of the RCFT

et al. 2021

Self Cite

View full text Add to dashboard Cite

In this study we attempted to replicate the classification accuracy of the newly introduced Forced Choice Recognition trial (FCR) of the Rey Complex Figure Test (RCFT) in a clinical sample. We administered the RCFT FCR and the earlier Yes/No Recognition trial from the RCFT to 52 clinically referred patients as part of a comprehensive neuropsychological test battery and incentivized a separate control group of 83 university students to perform well on these measures. We then computed the classification accuracies of both measures against criterion performance validity tests (PVTs) and compared results between the two samples. At previously published validity cutoffs (≤16 & ≤17), the RCFT FCR remained specific (.84–1.00) to psychometrically defined non-credible responding. Simultaneously, the RCFT FCR was more sensitive to examinees’ natural variability in visual-perceptual and verbal memory skills than the Yes/No Recognition trial. Even after being reduced to a seven-point scale (18-24) by the validity cutoffs, both RCFT recognition scores continued to provide clinically useful information on visual memory. This is the first study to validate the RCFT FCR as a PVT in a clinical sample. Our data also support its use for measuring cognitive ability. Replication studies with more diverse samples and different criterion measures are still needed before large-scale clinical application of this scale.

show abstract

“…Although participants were asked about momentary depression, the VAS also shows high short-term test-retest reliability (reliability coefficients, rxx = .80-.88). Moreover, the VAS is unaffected by age or gender (Sirianni et al, 2021).…”

Section: Depression Levelsmentioning

confidence: 97%

“…Their receiver operating characteristic curve (ROC) analysis demonstrated the VAS had good to excellent accuracy (ROC values ranging from 0.78-0.97) for detecting different depression levels (low-severe) corresponding to the Patient Health Questionnaire-9 cut-offs. Greater predictability and specificity have been reliably demonstrated for higher depression levels (Huang et al, 2020;Sirianni et al, 2021). Therefore, cut-offs for the current analysis are defined as <14 low depression, 14-67 moderate depression,  67 high levels of depression.…”

Section: Depression Levelsmentioning

confidence: 99%

“…Using a VAS to measure depression severity has been validated in individuals with depressive symptoms (Davies et al, 1975), in acutely stressing situations (Cella & Perry, 1986), and in non-clinical populations (Huang et al, 2020). Unlike other self-reported depression measures, the VAS does not depend on native English proficiency, thus being suitable for the current study (Sirianni et al, 2021). Although participants were asked about momentary depression, the VAS also shows high short-term test-retest reliability (reliability coefficients, rxx = .80-.88).…”

Section: Depression Levelsmentioning

confidence: 99%

See 1 more Smart Citation

Emotion networks across self-reported depression levels during the COVID-19 pandemic

Whiston

Igou

Fortune

2021

Cognition and Emotion

View full text Add to dashboard Cite

During stressful circumstances, such as the COVID-19 pandemic, disturbances in emotional experiences can occur. These emotional disturbances, if not relieved or regulated, can be associated with feelings of depression. Currently, little is known about which emotional experiences (positive and negative) are associated with feelings of depression during COVID-19. This study aimed to estimate and compare mixed, positive and negative valence emotion networks during COVID-19 for low, moderate and high levels of self-reported depression. Across 26,034 participants, central emotional experiences included gratitude, sadness, fear, anxiety, compassion, and being moved for all self-reported depression levels; love for low levels of depression, and confusion for high levels of depression. The strongest edges included fear-anxiety, loneliness-boredom, anger-disgust, determination-hope, and compassion-being moved for all self-reported depression levels; calm-relief, and sadnessfrustration for high levels of self-reported depression; and admiration-being moved for low and moderate self-reported depression levels. Network comparison tests showed mixed, positive and negative emotion networks significantly differed in structure across all selfreported depression levels. Network connectivity was also significantly stronger for low selfreported depression within positive and negative emotion networks. These networks provide key information on emotional experiences associated with depression during COVID-19.

show abstract

The V-5 provides quick, accurate and cross-culturally valid measures of psychiatric symptoms

Cited by 15 publications

References 49 publications

The use of online visual analogue scales in idiopathic pulmonary fibrosis

The use of online visual analogue scales in idiopathic pulmonary fibrosis

Flipping the Script: Measuring Both Performance Validity and Cognitive Ability with the Forced Choice Recognition Trial of the RCFT

Emotion networks across self-reported depression levels during the COVID-19 pandemic

Contact Info

Product

Resources

About